ARMISTICE CAPITAL, LLC — 13F Holdings & Portfolio
CIK 1601086 · latest 13F-HR filed 2026-05-15
ARMISTICE CAPITAL, LLC manages $5.62B in 13F-reported U.S. long-equity assets across 267 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are SPY (24.28%), IWM (15.43%), TVTX (2.59%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 102 new positions, exited 208, added to 39, and trimmed 97.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$5.62B
Long-equity book
267
Distinct positions
2026-03-31
Filed 2026-05-15
+102 / −208 / ↑39 / ↓97
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- HARMONY BIOSCIENCES HLDGS IN$26.8M +143.1%
- MEDLINE INC$22.7M +931.6%
- NEKTAR THERAPEUTICS$16.4M +65.0%
- ALIGN TECHNOLOGY INC$15.2M +127.9%
- UBER TECHNOLOGIES INC$14.2M +61.5%
Top Trims
- PTC THERAPEUTICS INC-$71.5M -33.6%
- KENVUE INC-$68.4M -99.3%
- IMMUNOVANT INC-$57.5M -39.4%
- GE HEALTHCARE TECHNOLOGIES I-$56.5M -87.0%
- DENTSPLY SIRONA INC-$48.6M -58.3%
New Positions
- UNITEDHEALTH GROUP INC$40.0M
- META PLATFORMS INC$18.6M
- CENTRAL GARDEN & PET CO$15.5M
- CAPRI HOLDINGS LIMITED$11.6M
- XERIS BIOPHARMA HOLDINGS INC$11.1M
Exited Positions
- ARGENX SE$48.8M
- STARBUCKS CORP$46.3M
- MEDTRONIC PLC$26.1M
- DANAHER CORPORATION$24.5M
- CVS HEALTH CORP$23.5M
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | STATE STR SPDR S&P 500 ETF T Put | SPY | 78462F103 | $1.37B | 24.28% | 2,100,000 | SH |
| 2 | ISHARES TR Put | IWM | 464287655 | $868.0M | 15.43% | 3,500,000 | SH |
| 3 | TRAVERE THERAPEUTICS INC | TVTX | 89422G107 | $145.5M | 2.59% | 4,897,417 | SH |
| 4 | PTC THERAPEUTICS INC | PTCT | 69366J200 | $141.3M | 2.51% | 2,074,449 | SH |
| 5 | AGIOS PHARMACEUTICALS INC Call | AGIO | 00847X104 | $108.3M | 1.92% | 3,200,000 | SH |
| 6 | SUPERNUS PHARMACEUTICALS | SUPN | 868459108 | $98.0M | 1.74% | 1,895,347 | SH |
| 7 | NEUROCRINE BIOSCIENCES INC | NBIX | 64125C109 | $95.4M | 1.70% | 724,000 | SH |
| 8 | AGIOS PHARMACEUTICALS INC | AGIO | 00847X104 | $91.9M | 1.63% | 2,716,000 | SH |
| 9 | IMMUNOVANT INC | IMVT | 45258J102 | $88.6M | 1.57% | 3,564,916 | SH |
| 10 | FRESHPET INC | FRPT | 358039105 | $64.5M | 1.15% | 1,093,307 | SH |
| 11 | INCYTE CORP | INCY | 45337C102 | $61.8M | 1.10% | 656,817 | SH |
| 12 | DYNE THERAPEUTICS INC | DYN | 26818M108 | $57.6M | 1.02% | 3,175,110 | SH |
| 13 | CYTOKINETICS INC Call | CYTK | 23282W605 | $56.0M | 1.00% | 850,000 | SH |
| 14 | CYTOKINETICS INC Call | CYTK | 23282W605 | $56.0M | 1.00% | 850,000 | SH |
| 15 | AMAZON COM INC | AMZN | 023135106 | $54.6M | 0.97% | 262,137 | SH |
| 16 | IRONWOOD PHARMACEUTICALS INC | IRWD | 46333X108 | $52.7M | 0.94% | 15,028,000 | SH |
| 17 | MADRIGAL PHARMACEUTICALS INC | MDGL | 558868105 | $52.3M | 0.93% | 100,000 | SH |
| 18 | MADRIGAL PHARMACEUTICALS INC | MDGL | 558868105 | $52.1M | 0.93% | 99,583 | SH |
| 19 | CYTOKINETICS INC | CYTK | 23282W605 | $50.4M | 0.90% | 764,538 | SH |
| 20 | HARMONY BIOSCIENCES HLDGS IN | HRMY | 413197104 | $45.5M | 0.81% | 1,624,000 | SH |
| 21 | THERMO FISHER SCIENTIFIC INC | TMO | 883556102 | $45.0M | 0.80% | 91,491 | SH |
| 22 | NEKTAR THERAPEUTICS | NKTR | 640268306 | $41.6M | 0.74% | 578,000 | SH |
| 23 | UNITEDHEALTH GROUP INC | UNH | 91324P102 | $40.0M | 0.71% | 148,000 | SH |
| 24 | UBER TECHNOLOGIES INC | UBER | 90353T100 | $37.3M | 0.66% | 518,760 | SH |
| 25 | IMMUNOCORE HLDGS PLC | IMCR | 45258D105 | $35.8M | 0.64% | 1,188,000 | SH |
| 26 | DENTSPLY SIRONA INC | XRAY | 24906P109 | $34.8M | 0.62% | 3,000,000 | SH |
| 27 | RIGEL PHARMACEUTICALS INC | RIGL | 766559702 | $34.6M | 0.62% | 1,280,000 | SH |
| 28 | DISC MEDICINE INC | IRON | 254604101 | $34.3M | 0.61% | 536,000 | SH |
| 29 | ALPHABET INC | GOOGL | 02079K305 | $34.1M | 0.61% | 118,514 | SH |
| 30 | MADRIGAL PHARMACEUTICALS INC | MDGL | 558868105 | $34.0M | 0.61% | 65,000 | SH |
| 31 | MINERALYS THERAPEUTICS INC | MLYS | 603170101 | $31.9M | 0.57% | 1,176,000 | SH |
| 32 | HUBSPOT INC | HUBS | 443573100 | $31.4M | 0.56% | 128,583 | SH |
| 33 | AXOGEN INC | AXGN | 05463X106 | $31.0M | 0.55% | 936,000 | SH |
| 34 | ORTHOFIX MED INC | OFIX | 68752M108 | $31.0M | 0.55% | 2,700,000 | SH |
| 35 | KURA ONCOLOGY INC | KURA | 50127T109 | $30.4M | 0.54% | 3,736,000 | SH |
| 36 | AVANOS MED INC | AVNS | 05350V106 | $28.0M | 0.50% | 2,000,000 | SH |
| 37 | REGENERON PHARMACEUTICALS | REGN | 75886F107 | $27.9M | 0.50% | 36,126 | SH |
| 38 | ALIGN TECHNOLOGY INC | ALGN | 016255101 | $27.1M | 0.48% | 157,959 | SH |
| 39 | PTC THERAPEUTICS INC Call | PTCT | 69366J200 | $26.6M | 0.47% | 390,000 | SH |
| 40 | MONGODB INC | MDB | 60937P106 | $26.3M | 0.47% | 107,296 | SH |
| 41 | ALIBABA GROUP HLDG LTD | BABA | 01609W102 | $25.6M | 0.46% | 204,000 | SH |
| 42 | MEDLINE INC | MDLN | 58507V107 | $25.1M | 0.45% | 564,857 | SH |
| 43 | KALVISTA PHARMACEUTICALS INC | KALV | 483497103 | $24.9M | 0.44% | 1,236,000 | SH |
| 44 | DATADOG INC | DDOG | 23804L103 | $24.6M | 0.44% | 208,564 | SH |
| 45 | HUMANA INC | HUM | 444859102 | $24.5M | 0.44% | 141,279 | SH |
| 46 | SENTINELONE INC | S | 81730H109 | $24.4M | 0.43% | 1,897,849 | SH |
| 47 | VERASTEM INC | VSTM | 92337C203 | $24.3M | 0.43% | 4,592,000 | SH |
| 48 | FIVE9 INC | FIVN | 338307101 | $24.2M | 0.43% | 1,592,000 | SH |
| 49 | INTUITIVE SURGICAL INC | ISRG | 46120E602 | $24.0M | 0.43% | 52,043 | SH |
| 50 | GRIFOLS S A | GRFS | 398438408 | $24.0M | 0.43% | 2,988,000 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | $5.62B | 267 | 0001315863-26-000414 |
| 2025-12-31 | 2026-02-17 | $8.40B | 370 | 0001315863-26-000163 |
| 2025-09-30 | 2025-11-17 | $6.74B | 332 | 0001315863-25-000814 |